When does Valneva report earnings and how could it move VLA.PA stock?

Valneva's earnings event is scheduled for the week of 18 Mar 2026. Expect price sensitivity to revenue versus guidance and pipeline updates; strong commercial or clinical news could lift VLA.PA stock, while weak guidance may pressure the share price.

What are the most important metrics to watch in the VLA.PA earnings report?

Watch revenue growth, gross margin, R&D spend, free cash flow, and management guidance on VLA1553 and VLA15. Given EPS **-0.65**, cash flow and funding commentary are particularly relevant for VLA.PA stock.

What is Meyka AI's short‑term forecast for VLA.PA stock?

Meyka AI's model gives a monthly projection of **€3.86** and a quarterly projection of **€5.73**. These model projections signal possible short‑term downside or upside depending on the earnings tone, and are not guaranteed outcomes.

How does valuation look for Valneva on EURONEXT?

Valneva trades at price‑to‑sales **4.34** and price‑to‑book **4.90**, with negative PE **-6.94**. These ratios reflect premium expectations versus current profitability and underline the importance of upcoming commercial results for VLA.PA stock.

EU Stocks

Valneva SE (VLA.PA EURONEXT) after hours: Q4 earnings preview 13 Mar 2026

ByHuzaifa Zahoor March 13, 2026March 13, 2026

Valneva SE (VLA.PA) trades at €4.53 after hours on 13 Mar 2026, down -5.31% on the day, as investors position ahead of Q4 results and a scheduled earnings call. The biotech’s upcoming report and management commentary on vaccine sales and R&D spend are the immediate catalysts for VLA.PA stock. Volume is elevated at 839,847 shares versus a 30‑day average of 1,025,640, signalling higher trader interest. We summarise the key figures, model-driven forecasts, and what to watch in the EURONEXT Europe session for VLA.PA stock.